Literature DB >> 2199820

Protein H--a novel IgG binding bacterial protein.

P Akesson1, J Cooney, F Kishimoto, L Björck.   

Abstract

Forty-eight group A streptococcal strains of different M types were screened for binding of human radiolabeled IgG. Three of the strains bound more than 80% of the added radioactivity and one of them, an M protein type 1 strain designated AP1, was selected for further analysis. Attempts were made to solubilize the IgG binding bacterial molecule, and small amounts of an IgG binding protein with a mol. wt of 40 kDa could be solubilized with mutanolysin, a muramolytic agent. The gene encoding this streptococcal protein was cloned and expressed in E. coli, and the E. coli-produced protein was purified in a single step by affinity chromatography on IgG-Sepharose. When tested with IgGs from different species, the molecule was found to bind human IgG almost exclusively. The N-terminal amino acid sequence was determined and showed no homology with previously isolated Ig binding proteins, and the name protein H (as in human IgG) is suggested for this novel Ig binding bacterial protein. Protein H showed preferential affinity for heavy chains and Fc fragments of human IgG, and did not bind Ig light chains. The affinity constant, determined by Scatchard plots, between protein H and human polyclonal IgG was 1.6 x 10(9). No binding was observed between protein H and IgM, IgA, IgD, or IgE. Finally, when tested against several additional proteins and human plasma, protein H only showed weak binding to alpha 2-macroglobulin, a proteinase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199820     DOI: 10.1016/0161-5890(90)90071-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  31 in total

1.  Convergent evolution among immunoglobulin G-binding bacterial proteins.

Authors:  I M Frick; M Wikström; S Forsén; T Drakenberg; H Gomi; U Sjöbring; L Björck
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.

Authors:  Anna M Blom; Michal Magda; Lisa Kohl; Jutamas Shaughnessy; John D Lambris; Sanjay Ram; David Ermert
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

3.  Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.

Authors:  David Ermert; Antonin Weckel; Michal Magda; Matthias Mörgelin; Jutamas Shaughnessy; Peter A Rice; Lars Björck; Sanjay Ram; Anna M Blom
Journal:  J Immunol       Date:  2018-04-06       Impact factor: 5.422

Review 4.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

5.  EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG.

Authors:  M Collin; A Olsén
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.

Authors:  Mattias Collin; Mikael D Svensson; Anders G Sjöholm; Jens C Jensenius; Ulf Sjöbring; Arne Olsén
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Protein H, an antiphagocytic surface protein in Streptococcus pyogenes.

Authors:  B M Kihlberg; M Collin; A Olsén; L Björck
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

8.  Streptococcus pyogenes infection in mouse skin leads to a time-dependent up-regulation of protein H expression.

Authors:  Tara C Smith; Darren D Sledjeski; Michael D P Boyle
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood.

Authors:  Anna Eriksson; Mari Norgren
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Protein C inhibitor--a novel antimicrobial agent.

Authors:  Erik Malmström; Matthias Mörgelin; Martin Malmsten; Linda Johansson; Anna Norrby-Teglund; Oonagh Shannon; Artur Schmidtchen; Joost C M Meijers; Heiko Herwald
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.